David J Nutt
Affiliations: | Neuropsychopharmacology and Molecular Imaging | Imperial College London, London, England, United Kingdom |
Google:
"David Nutt"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Colin Blakemore | collaborator | 2006- | Imperial College London |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nestor LJ, Suckling J, Ersche KD, et al. (2020) Disturbances across whole brain networks during reward anticipation in an abstinent addiction population. Neuroimage. Clinical. 27: 102297 |
| Nutt D, Erritzoe D, Carhart-Harris R. (2020) Psychedelic Psychiatry's Brave New World. Cell. 181: 24-28 |
| Jefsen O, Højgaard K, Christiansen SL, et al. (2019) Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat. Acta Neuropsychiatrica. 1-7 |
| Sessa B, Higbed L, Nutt D. (2019) A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy. Frontiers in Psychiatry. 10: 138 |
| Nutt D. (2019) Psychedelic drugs-a new era in psychiatry? . Dialogues in Clinical Neuroscience. 21: 139-147 |
| Nestor LJ, Paterson LM, Murphy A, et al. (2018) Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and poly-substance dependent individuals. The European Journal of Neuroscience |
| Tyacke RJ, Myers JFM, Venkataraman A, et al. (2018) Evaluation ofC-BU99008, a positron emission tomography ligand for the Imidazolinebinding site in human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Rucker JJH, Iliff J, Nutt DJ. (2017) Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology |
| Carhart-Harris RL, Roseman L, Bolstridge M, et al. (2017) Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports. 7: 13187 |
| Law FD, Diaper AM, Melichar JK, et al. (2017) Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals. Journal of Psychopharmacology (Oxford, England). 269881117711710 |